SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-017576
Filing Date
2019-09-30
Accepted
2019-09-30 17:06:06
Documents
12
Period of Report
2019-09-27
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 23824
  Complete submission text file 0001140361-19-017576.txt   162222

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20190927.xsd EX-101.SCH 4389
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20190927_lab.xml EX-101.LAB 23692
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20190927_pre.xml EX-101.PRE 16832
10 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4062
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 191126679
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences